Titre du document / Document title

Confluent and reticulated papillomatosis : Response to minocycline

Auteur(s) / Author(s)

MONTEMARANO A. D. ⁽¹⁾ ; HENGGE M. ; PURNIMA SAU ⁽¹⁾ ; WELCH M. ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

⁽¹⁾ Department of Dermatology, Walter Reed Army Medical Center, Washington, D.C., ETATS-UNIS

Résumé / Abstract

Background : Confluent and reticulated papillomatosis (CRP) of Gougerot and Carteaud is an uncommon disorder of unknown cause for which a variety of treatments have been proposed. Objective : We attempted to evaluate the effectiveness of oral minocycline. Methods : Nine patients with CRP were treated with oral minocycline, 50 mg twice a day, for 6 weeks. The average follow-up period was 11 months. Recurrence rate, side effects, and effectiveness of therapy were assessed. Results : All patients except two had a 90% to 100% response to therapy. Recurrences were noted in three patients, all of whom responded to re-treatment with minocycline. None of the nine patients had an adverse reaction. Conclusion : Minocycline, 50 mg twice a day, is safe and effective for CRP.

Revue / Journal Title

Journal of the American Academy of Dermatology   ISSN 0190-9622   CODEN JAADDB 

Source / Source

1996, vol. 34 (1), n^o2, pp. 253-256 (18 ref.)

Langue / Language

Anglais

Editeur / Publisher

Elsevier, New York, NY, ETATS-UNIS  (1979) (Revue)

Mots-clés anglais / English Keywords

Confluent and reticulate papillomatosis Gougerot Carteaud ; Treatment ; Chemotherapy ; Clinical trial ; Antibiotic ; Treatment efficiency ; Tetracycline derivatives ; Skin disease ; Benign neoplasm ;

Mots-clés français / French Keywords

Papillomatose confluente réticulée Gougerot Carteaud ; Traitement ; Chimiothérapie ; Minocycline ; Essai clinique ; Antibiotique ; Efficacité traitement ; Tétracycline dérivé ; Peau pathologie ; Tumeur bénigne ;

Mots-clés espagnols / Spanish Keywords

Papilomatosis confluente reticulada Gougerot Carteaud ; Tratamiento ; Quimioterapia ; Ensayo clínico ; Antibiótico ; Eficacia tratamiento ; Tetraciclina derivado ; Piel patología ; Tumor benigno ;

Localisation / Location

INIST-CNRS, Cote INIST : 18387, 35400005302436.0110